Beverages - Alcoholic
Compare Stocks
5 / 10Stock Comparison
BUD vs SAM vs TAP vs STZ vs CCK
Revenue, margins, valuation, and 5-year total return — side by side.
Beverages - Alcoholic
Beverages - Alcoholic
Beverages - Wineries & Distilleries
Packaging & Containers
BUD vs SAM vs TAP vs STZ vs CCK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Beverages - Alcoholic | Beverages - Alcoholic | Beverages - Alcoholic | Beverages - Wineries & Distilleries | Packaging & Containers |
| Market Cap | $137.47B | $2.12B | $7.96B | $25.70B | $11.36B |
| Revenue (TTM) | $119.82B | $2.09B | $11.19B | $9.38B | $12.37B |
| Net Income (TTM) | $12.57B | $-61M | $-2.11B | $1.11B | $737M |
| Gross Margin | 55.2% | 45.2% | 37.8% | 52.0% | 18.3% |
| Operating Margin | 31.7% | -3.8% | -20.3% | 34.5% | 13.2% |
| Forward P/E | 18.7x | 20.8x | 8.9x | 12.5x | 12.5x |
| Total Debt | $72.17B | $38M | $6.30B | $12.11B | $6.17B |
| Cash & Equiv. | $11.17B | $223M | $897M | $68M | $879M |
BUD vs SAM vs TAP vs STZ vs CCK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Anheuser-Busch InBe… (BUD) | 100 | 170.4 | +70.4% |
| The Boston Beer Com… (SAM) | 100 | 34.9 | -65.1% |
| Molson Coors Bevera… (TAP) | 100 | 111.7 | +11.7% |
| Constellation Brand… (STZ) | 100 | 85.8 | -14.2% |
| Crown Holdings, Inc. (CCK) | 100 | 154.7 | +54.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BUD vs SAM vs TAP vs STZ vs CCK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BUD is the #2 pick in this set and the best alternative if momentum and efficiency is your priority.
- +21.2% vs STZ's -20.4%
- 6.0% ROA vs TAP's -8.9%, ROIC 7.5% vs -10.1%
SAM is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 3.7%, EPS growth 95.5%, 3Y rev CAGR -0.0%
- Lower volatility, beta 0.31, Low D/E 4.5%, current ratio 1.65x
TAP carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 5 yrs, beta 0.02, yield 4.5%
- Beta 0.02, yield 4.5%, current ratio 0.55x
- Lower P/E (8.9x vs 12.5x)
- Beta 0.02 vs CCK's 0.50, lower leverage
STZ ranks third and is worth considering specifically for quality.
- 11.8% margin vs TAP's -18.9%
CCK is the clearest fit if your priority is long-term compounding.
- 98.1% 10Y total return vs BUD's -23.9%
- 4.8% revenue growth vs TAP's -4.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.8% revenue growth vs TAP's -4.2% | |
| Value | Lower P/E (8.9x vs 12.5x) | |
| Quality / Margins | 11.8% margin vs TAP's -18.9% | |
| Stability / Safety | Beta 0.02 vs CCK's 0.50, lower leverage | |
| Dividends | 4.5% yield, 5-year raise streak, vs CCK's 1.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +21.2% vs STZ's -20.4% | |
| Efficiency (ROA) | 6.0% ROA vs TAP's -8.9%, ROIC 7.5% vs -10.1% |
BUD vs SAM vs TAP vs STZ vs CCK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
BUD vs SAM vs TAP vs STZ vs CCK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TAP leads in 1 of 6 categories
SAM leads 1 • BUD leads 1 • STZ leads 0 • CCK leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — BUD and STZ each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BUD is the larger business by revenue, generating $119.8B annually — 57.2x SAM's $2.1B. STZ is the more profitable business, keeping 11.8% of every revenue dollar as net income compared to TAP's -18.9%. On growth, CCK holds the edge at +7.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $119.8B | $2.1B | $11.2B | $9.4B | $12.4B |
| EBITDAEarnings before interest/tax | $38.8B | $14M | -$1.5B | $3.7B | $2.1B |
| Net IncomeAfter-tax profit | $12.6B | -$61M | -$2.1B | $1.1B | $737M |
| Free Cash FlowCash after capex | $32.2B | $191M | $1.2B | $1.8B | $1.1B |
| Gross MarginGross profit ÷ Revenue | +55.2% | +45.2% | +37.8% | +52.0% | +18.3% |
| Operating MarginEBIT ÷ Revenue | +31.7% | -3.8% | -20.3% | +34.5% | +13.2% |
| Net MarginNet income ÷ Revenue | +10.5% | -2.9% | -18.9% | +11.8% | +6.0% |
| FCF MarginFCF ÷ Revenue | +26.9% | +9.1% | +10.4% | +18.8% | +8.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +0.4% | +1.7% | +2.0% | -9.8% | +7.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +32.3% | -7.4% | +35.6% | -15.0% | -56.6% |
Valuation Metrics
TAP leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 15.9x trailing earnings, CCK trades at a 43% valuation discount to BUD's 27.9x P/E. On an enterprise value basis, CCK's 8.0x EV/EBITDA is more attractive than BUD's 9.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $137.5B | $2.1B | $8.0B | $25.7B | $11.4B |
| Enterprise ValueMkt cap + debt − cash | $198.5B | $1.9B | $13.4B | $37.7B | $16.7B |
| Trailing P/EPrice ÷ TTM EPS | 27.93x | 19.95x | -3.91x | -329.36x | 15.86x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.69x | 20.77x | 8.95x | 12.53x | 12.47x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.05x |
| EV / EBITDAEnterprise value multiple | 9.44x | 8.21x | — | 9.28x | 7.96x |
| Price / SalesMarket cap ÷ Revenue | 2.30x | 1.01x | 0.71x | 2.52x | 0.92x |
| Price / BookPrice ÷ Book value/share | 1.84x | 2.47x | 0.79x | 3.77x | 3.37x |
| Price / FCFMarket cap ÷ FCF | 12.28x | 9.82x | 7.46x | 13.26x | 10.34x |
Profitability & Efficiency
SAM leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CCK delivers a 21.8% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-19 for TAP. SAM carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCK's 1.77x. On the Piotroski fundamental quality scale (0–9), BUD scores 9/9 vs TAP's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +13.8% | -7.3% | -18.6% | +13.9% | +21.8% |
| ROA (TTM)Return on assets | +6.0% | -5.0% | -8.9% | +5.1% | +5.2% |
| ROICReturn on invested capital | +7.5% | +15.5% | -10.1% | +13.0% | +14.1% |
| ROCEReturn on capital employed | +8.7% | +14.8% | -11.6% | +18.0% | +16.0% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 7 | 4 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.81x | 0.04x | 0.60x | 1.70x | 1.77x |
| Net DebtTotal debt minus cash | $61.0B | -$186M | $5.4B | $12.0B | $5.3B |
| Cash & Equiv.Liquid assets | $11.2B | $223M | $897M | $68M | $879M |
| Total DebtShort + long-term debt | $72.2B | $38M | $6.3B | $12.1B | $6.2B |
| Interest CoverageEBIT ÷ Interest expense | 2.53x | — | -9.99x | 5.47x | 4.00x |
Total Returns (Dividends Reinvested)
BUD leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BUD five years ago would be worth $11,300 today (with dividends reinvested), compared to $1,736 for SAM. Over the past 12 months, BUD leads with a +21.2% total return vs STZ's -20.4%. The 3-year compound annual growth rate (CAGR) favors BUD at 8.8% vs SAM's -14.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +27.2% | -1.3% | -9.5% | +6.4% | -2.5% |
| 1-Year ReturnPast 12 months | +21.2% | -19.4% | -18.4% | -20.4% | +5.1% |
| 3-Year ReturnCumulative with dividends | +28.7% | -36.8% | -25.9% | -29.9% | +23.6% |
| 5-Year ReturnCumulative with dividends | +13.0% | -82.6% | -15.4% | -30.4% | -6.0% |
| 10-Year ReturnCumulative with dividends | -23.9% | +28.4% | -42.1% | +11.4% | +98.1% |
| CAGR (3Y)Annualised 3-year return | +8.8% | -14.2% | -9.5% | -11.2% | +7.3% |
Risk & Volatility
Evenly matched — BUD and TAP each lead in 1 of 2 comparable metrics.
Risk & Volatility
TAP is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than CCK's 0.50 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BUD currently trades 96.4% from its 52-week high vs TAP's 73.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.33x | 0.31x | 0.02x | 0.28x | 0.50x |
| 52-Week HighHighest price in past year | $82.91 | $264.46 | $57.57 | $196.91 | $116.62 |
| 52-Week LowLowest price in past year | $56.97 | $185.34 | $40.64 | $126.45 | $89.21 |
| % of 52W HighCurrent price vs 52-week peak | +96.4% | +74.6% | +73.7% | +75.3% | +86.8% |
| RSI (14)Momentum oscillator 0–100 | 64.2 | 27.1 | 49.5 | 43.3 | 47.0 |
| Avg Volume (50D)Average daily shares traded | 2.0M | 199K | 2.9M | 1.8M | 984K |
Analyst Outlook
Evenly matched — TAP and CCK each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BUD as "Buy", SAM as "Hold", TAP as "Hold", STZ as "Buy", CCK as "Buy". Consensus price targets imply 21.5% upside for SAM (target: $240) vs 10.8% for TAP (target: $47). For income investors, TAP offers the higher dividend yield at 4.53% vs CCK's 1.02%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $89.00 | $239.78 | $47.00 | $175.70 | $120.50 |
| # AnalystsCovering analysts | 45 | 31 | 37 | 46 | 25 |
| Dividend YieldAnnual dividend ÷ price | +1.6% | — | +4.5% | +2.7% | +1.0% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 5 | 4 | 8 |
| Dividend / ShareAnnual DPS | $1.31 | — | $1.92 | $4.03 | $1.04 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | +9.7% | +8.1% | +4.4% | +4.4% |
TAP leads in 1 of 6 categories (Valuation Metrics). SAM leads in 1 (Profitability & Efficiency). 3 tied.
BUD vs SAM vs TAP vs STZ vs CCK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BUD or SAM or TAP or STZ or CCK a better buy right now?
For growth investors, Crown Holdings, Inc.
(CCK) is the stronger pick with 4. 8% revenue growth year-over-year, versus -4. 2% for Molson Coors Beverage Company (TAP). Crown Holdings, Inc. (CCK) offers the better valuation at 15. 9x trailing P/E (12. 5x forward), making it the more compelling value choice. Analysts rate Anheuser-Busch InBev SA/NV (BUD) a "Buy" — based on 45 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BUD or SAM or TAP or STZ or CCK?
On trailing P/E, Crown Holdings, Inc.
(CCK) is the cheapest at 15. 9x versus Anheuser-Busch InBev SA/NV at 27. 9x. On forward P/E, Molson Coors Beverage Company is actually cheaper at 8. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — BUD or SAM or TAP or STZ or CCK?
Over the past 5 years, Anheuser-Busch InBev SA/NV (BUD) delivered a total return of +13.
0%, compared to -82. 6% for The Boston Beer Company, Inc. (SAM). Over 10 years, the gap is even starker: CCK returned +98. 1% versus TAP's -42. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BUD or SAM or TAP or STZ or CCK?
By beta (market sensitivity over 5 years), Molson Coors Beverage Company (TAP) is the lower-risk stock at 0.
02β versus Crown Holdings, Inc. 's 0. 50β — meaning CCK is approximately 2166% more volatile than TAP relative to the S&P 500. On balance sheet safety, The Boston Beer Company, Inc. (SAM) carries a lower debt/equity ratio of 4% versus 177% for Crown Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BUD or SAM or TAP or STZ or CCK?
By revenue growth (latest reported year), Crown Holdings, Inc.
(CCK) is pulling ahead at 4. 8% versus -4. 2% for Molson Coors Beverage Company (TAP). On earnings-per-share growth, the picture is similar: The Boston Beer Company, Inc. grew EPS 95. 5% year-over-year, compared to -302. 8% for Molson Coors Beverage Company. Over a 3-year CAGR, STZ leads at 5. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BUD or SAM or TAP or STZ or CCK?
Anheuser-Busch InBev SA/NV (BUD) is the more profitable company, earning 9.
8% net margin versus -19. 2% for Molson Coors Beverage Company — meaning it keeps 9. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: STZ leads at 35. 5% versus -21. 0% for TAP. At the gross margin level — before operating expenses — BUD leads at 55. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BUD or SAM or TAP or STZ or CCK more undervalued right now?
On forward earnings alone, Molson Coors Beverage Company (TAP) trades at 8.
9x forward P/E versus 20. 8x for The Boston Beer Company, Inc. — 11. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SAM: 21. 5% to $239. 78.
08Which pays a better dividend — BUD or SAM or TAP or STZ or CCK?
In this comparison, TAP (4.
5% yield), STZ (2. 7% yield), BUD (1. 6% yield), CCK (1. 0% yield) pay a dividend. SAM does not pay a meaningful dividend and should not be held primarily for income.
09Is BUD or SAM or TAP or STZ or CCK better for a retirement portfolio?
For long-horizon retirement investors, Molson Coors Beverage Company (TAP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
02), 4. 5% yield). Both have compounded well over 10 years (TAP: -42. 1%, SAM: +28. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BUD and SAM and TAP and STZ and CCK?
These companies operate in different sectors (BUD (Consumer Defensive) and SAM (Consumer Defensive) and TAP (Consumer Defensive) and STZ (Consumer Defensive) and CCK (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BUD is a mid-cap quality compounder stock; SAM is a small-cap quality compounder stock; TAP is a small-cap income-oriented stock; STZ is a mid-cap quality compounder stock; CCK is a mid-cap deep-value stock. BUD, TAP, STZ, CCK pay a dividend while SAM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.